HF
SCLN

Hoxton Financial’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Hoxton Financial’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-659
Closed -$3K – 667
2013
Q4 		$3K Buy
+659
New +$3.17K ﹤0.01% 618

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
QBFM
QS Batterymarch Financial Management New York $3.78B AUM 22.02% 1-Year Est. Return

Hoxton Financial's SCLN Position: Q1 2014 in Review

Hoxton Financial sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q1 2014, closing a stake of 659 shares — an estimated $3K sold.

Hoxton Financial first reported a position in SCLN in Q4 2013 and held it in 1 quarter. The position peaked at $3K in Q4 2013. 96 funds tracked by Wall St. Rank hold SCLN as of Q1 2014.

  • Hoxton Financial reported no remaining Sciclone Pharmaceuticals Inc position as of Q1 2014 after selling out during the quarter.
  • Hoxton Financial sold 659 Sciclone Pharmaceuticals Inc shares in Q1 2014, an estimated $3K.
  • Hoxton Financial first reported a position in Sciclone Pharmaceuticals Inc in Q4 2013 and held it in 1 quarter.
  • Hoxton Financial's Sciclone Pharmaceuticals Inc position peaked at $3K in Q4 2013.
  • 96 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q1 2014.

Based on Hoxton Financial's 13F filing for Q1 2014, filed 25 Apr 2014.